Press Release Oct 23 2020

Biocon Limited has informed the Exchange regarding a press release dated October 22, 2020, titled "Biocon Q2FY21 Revenue at Rs 1,760 Cr, Up 10%; EBITDA atRs 407 Cr; Net Profit (before exceptional item & discontinuing operations) at Rs 174 Cr; Generics Up 8% at Rs 599 Cr; Biosimilars Up 11% at Rs 676 Cr; Research Services Up 12% at Rs 520 Cr. ".

View Attachment